Covetrus, Inc. (NASDAQ:CVET) is set to announce third quarter earning results on Tuesday 10th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CVET to report 3Q20 income of $ 0.18 per share.
For the full year, analysts anticipate top line of $ 4176.84 million, while looking forward to income of $ 0.73 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 4,025.00 million ~ $ 4,125.00 million
Click Here For More Historical Outlooks Of Covetrus, Inc.
Previous Quarter Performance
Covetrus, Inc. disclosed income for the second quarter of $ 0.27 per share, from the revenue of $ 1,026.00 million. The quarterly earnings elevated 107.69 percent while revenues extended 1.68 percent compared with the same quarter last year.
The consensus estimates are income of $ 0.08 per share from $ 883.47 million in revenue. The bottom line results beat street analysts by $ 0.19 or 237.50 percent, at the same time, top line results outshined analysts by $ 142.53 million or 16.13 percent.
Stock Performance
Shares of Covetrus, Inc. traded low $ -1.66 or -5.87 percent on Monday, reaching $ 26.63 with volume of 1.18 million shares. Covetrus, Inc. has traded high as $ 30.13 and has cracked $ 26.59 on the downward trend
According to the previous trading day, closing price of $ 26.63, representing a 598.52 % increase from the 52 week low of $ 4.05 and a 6.11 % decrease over the 52 week high of $ 30.13.
The company has a market capital of $ 3.39 billion and is part of the Technology sector and Health Information Services industry.
Recent Analyst recommendations
- On 16th September 2020, upgraded by Stifel Nicolaus to Buy from Hold rating.
Conference Call
Covetrus, Inc. will be hosting a conference call at 4:30 PM eastern time on 10th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.covetrus.com
Covetrus, Inc. operates as an animal-health technology and services company. It operates through two segments, Supply Chain, and Technology and Value-Added Services.
